Vitamin K-2 100 mcg - 100 Vcaps®
Item#: 0990
Manufacturer SKU: 733739009906
- Most Biologically Active Form
- Supports a Healthy Cardiovascular System*
- With 300 mg of Alfalfa
- A Dietary Supplement
- Vegetarian Formula
Although Vitamin K is best known for its role in normal blood clotting function, recent research has revealed Vitamin K's beneficial effects on bone and cardiovascular health. In bone tissue, Vitamin K is critical for the formation of healthy, strong bone matrix. In fact, bone quality is dependent on the presence of adequate Vitamin K. Vitamin K's role in arterial health revolves around its ability to support proper calcium metabolism in vascular structures. Vitamin K2 is the most biologically active form of vitamin K. It is also the most beneficial for bone integrity, as well as for the support of arterial health.* This product also includes the addition of Alfalfa which is typically known to be a rich source of natural Vitamin K.
Suggested Usage
As a dietary supplement, take one Vcap® daily with a meal.
| Serving Size: | 1 Vcap® | ||
|---|---|---|---|
| Servings Per Container: | 100 | ||
| Amount Per Serving | % Daily Value* | ||
|
* Percent Daily Values are based on 2,000 calorie diet. † Daily Value not established. |
|||
| Vitamin K2 (as Menaquinone) | 100 mcg | 125% | |
| Alfalfa (Medicago sativa) | 300 mg | † | |
Other Ingredients: Cellulose (capsule), Rice Flour, Maltodextrin, Ascorbyl Palmitate and Silica.
Contains no: sugar, salt, wheat, gluten, soy, milk, egg, shellfish or preservatives. Vegetarian/Vegan Product.
Caution: Consult your health practitioner before consumption if you are currently taking any anti-coagulant drugs (such as warfarin, coumadin, heparin), or if you are pregnant/lactating.
Do Not Eat Freshness Packet. Keep in Bottle.
Vcaps® is a registered trademark of Capsugel.
Store in a cool, dry place. Please Recycle.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
This information current as of 3/7/14 2:12 PM.
E-Newsletter sign-up
Facebook
Twitter